Guo Zhu Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guo Zhu Zheng has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Andrew O. Stewart
Neuroscience Research, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6115
3 shared publicationsChih-Hung Lee
2 shared publicationsHaixia Yu
2 shared publicationsJoseph Mikusa
2 shared publicationsKathy Kohlhaas
2 shared publicationsSteve McGaraughty
2 shared publications
Latest Publications
- 21 October 2005
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (23) , 7374-7388
Structure−Activity Relationship of Triazafluorenone Derivatives as Potent and Selective mGluR1 Antagonists
SAR (structure−activity relationship) studies of triazafluorenone derivatives as potent mGluR1 antagonists are described. The triazafluorenone derivatives are non-amino acid derivatives and noncompetitive mGluR1 antagonists that bind at a putative allosteric recognition site located within the seven-transmembrane domain of the receptor. These triazafluorenone derivatives are potent, selective, and systemically active mGluR1 antagonists. Compound 1n, for example, was a very potent mGluR1 antagonist (IC50 = 3 nM) and demonstrated full efficacy in various in vivo animal pain models.
- 21 October 2005
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (23) , 7374-7388
Structure−Activity Relationship of Triazafluorenone Derivatives as Potent and Selective mGluR1 Antagonists
SAR (structure−activity relationship) studies of triazafluorenone derivatives as potent mGluR1 antagonists are described. The triazafluorenone derivatives are non-amino acid derivatives and noncompetitive mGluR1 antagonists that bind at a putative allosteric recognition site located within the seven-transmembrane domain of the receptor. These triazafluorenone derivatives are potent, selective, and systemically active mGluR1 antagonists. Compound 1n, for example, was a very potent mGluR1 antagonist (IC50 = 3 nM) and demonstrated full efficacy in various in vivo animal pain models.
- 1 September 2003
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (18) , 3041-3044
Adenosine kinase inhibitors: polar 7-Substitutent of pyridopyrimidine derivatives improving their locomotor selectivity
- 1 September 2003
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (18) , 3041-3044
Adenosine kinase inhibitors: polar 7-Substitutent of pyridopyrimidine derivatives improving their locomotor selectivity
- 1 August 2001
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (16) , 2071-2074
Pyridopyrimidine analogues as novel adenosine kinase inhibitors
- 1 August 2001
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (16) , 2071-2074
Pyridopyrimidine analogues as novel adenosine kinase inhibitors
- 31 December 2000
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 2000 (09) , 1324-1326
2-Siloxy-4-furanyl Anion: Remarkable Solvent Effect on Its Nucleophilicity
A significant solvent effect was observed for 2-triisopropylsiloxyl-4-furanyllithium complex (II) in nucleophilic addition of ketones. THF was found to be the best solvent in terms of yields and diastereoselectivity.
- 31 December 2000
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 2000 (09) , 1324-1326
2-Siloxy-4-furanyl Anion: Remarkable Solvent Effect on Its Nucleophilicity
A significant solvent effect was observed for 2-triisopropylsiloxyl-4-furanyllithium complex (II) in nucleophilic addition of ketones. THF was found to be the best solvent in terms of yields and diastereoselectivity.